艾森门格综合征的脑代谢物改变:磁共振质子波谱评估
研究纳入10例确诊艾森门格综合征的先天性心脏病患儿与10例健康志愿儿童,采用1.5T MRI单 voxel 波谱采集左侧额叶皮层下白质、左侧豆状核和左侧丘脑的谱峰积分值。结果显示患者额叶皮层下区域和丘脑的胆碱代谢物水平显著低于对照组,其他代谢物(NAA、Cr、mI、Glx)组间无统计学显著差异;豆状核胆碱均值虽低于对照组但未达统计学显著。
要点
- 艾森门格综合征患儿额叶皮层下白质和丘脑的胆碱(Cho)水平显著低于健康对照。
- NAA、Cr、mI、Glx 水平在患者与对照之间无统计学显著差异。
- 3例患者可见脑室周围白质高信号。
核心结论
- 胆碱代谢物在艾森门格综合征患者的脑代谢中起重要作用,口服胆碱治疗可能有助于延长生存。
研究设计与样本
- 研究纳入10例(男3例、女7例)确诊艾森门格综合征的先天性心脏病患儿,对照组为10例健康志愿儿童;全部使用1.5T MRI扫描仪,采用单 voxel 波谱从左侧额叶皮层下白质、左侧豆状核和左侧丘脑三个不同区域获取谱图,以谱峰积分值作为定量数据。
关键影像表现/征象
- 3例患者观察到脑室周围白质高信号。
- 患者额叶皮层下区域和丘脑的胆碱(Cho)水平显著低于对照组。
- 豆状核 Cho 平均值在艾森门格综合征患者中低于对照组,但无统计学显著差异。
诊断标准与关键数值
- 与对照组相比,艾森门格综合征患者额叶皮层下区域和丘脑的胆碱(Cho)水平显著降低。
- NAA、Cr、mI 和 Glx 水平在患者与对照之间无统计学显著差异。
- 豆状核 Cho 平均值在患者中低于对照组,但未达统计学显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Eisenmenger syndrome (ES) is a life-threatening disease characterized by pulmonary hypertension and cyanosis in patients with congenital heart diseases. The aim of this study was to determine the brain metabolite changes in Eisenmenger syndrome compared with a control group using MR proton spectroscopy.
METHODS AND MATERIALS: The study included 10 children (3 male, 7 female) with congenital heart diseases and a diagnosis of Eisenmenger syndrome. The control group consisted of 10 healthy volunteer children. All were examined with a 1.5T MRI scanner and single voxel spectroscopy was performed to obtain spectra from three different regions; left frontal subcortical white matter, left lentiform nucleus and left thalamus. Peak integral values obtained from the spectra were used as quantitative data.
RESULTS: The ages of the children with ES were between 5 and 16 years, and between 5 and 15 years in the control group. Periventricular white matter hyperintensities were observed in 3 patients. On MR spectroscopy study, significantly lower levels of Choline metabolite (Cho) were detected in the frontal subcortical region and thalamus regions of the patients compared with the control group. There was no statistically significant difference between the levels of other metabolites (NAA, Cr, mI and Glx). In the lentiform nucleus, although the average value of Cho in ES patients was lower than that of the control group, it was not statistically significant.
CONCLUSION: Cho metabolite was determined to have an important role in brain metabolism in Eisenmenger syndrome patients. Oral Cho treatment may help to extend survival.
引用
- Dokumacı DŞ, Doğan F, Yıldırım A, et al. Brain metabolite alterations in Eisenmenger syndrome: Evaluation with MR proton spectroscopy. Eur J Radiol. 2016. PMID: 28027769. doi:10.1016/j.ejrad.2016.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。